Researchers who participated in the JPIAMR workshop on environment in September 2017 have now published a journal article of findings from the workshop. The article, Critical knowledge gaps and research needs related to the environmental dimensions of antibiotic resistance, was published in Environment International.
Read more about the JPIAMR workshop on Environmental Dimensions of AMR here.
JPIAMR recognises a need to reinforce alignment of AMR research; to address this need the JPIAMR will establish a Virtual Research Institute in AMR (“the JPIAMR-VRI”), a Global Network connecting research performing organisations including institutes, centres, and infrastructures to each other across sectorial and geographic boundaries in a larger global network.
The intent of the JPIAMR-VRI Network Call is to help develop a platform that will identify research community needs in AMR and develop ideas to form the foundation of the JPIAMR-VRI. The funded Network Working Groups are expected to generate catalytic ideas and strategic plans to help JPIAMR bring the JPIAMR-VRI to life!
Up to 21 Networks will be funded with up to 50,000 € each to connect experts from research performing organisations, institutes, centres and infrastructures and establish expertise clusters in the AMR community. Note that JPIAMR Network calls do not fund research projects.
More information on the 8th call – JPIAMR-VRI Network Call 2018, can be found at the call webpage: utveckling.jpiamr.eu/8thcall
We are pleased to announce that Katherine Payne, Professor of Health Economics, The University of Manchester, has been elected as new member of the JPIAMR Scientific Advisory Board.
Professor Katherine Payne was awarded a personal chair in health economics at The University of Manchester in August 2010. Katherine is also a registered pharmacist and was awarded the status of Fellow of the Royal Pharmaceutical Society in 2016. She is now based within the Manchester Centre for Health Economics at The University of Manchester. She holds honorary positions with: the School of Pharmacy, University of Nottingham; PHG Foundation, Cambridge; Central Manchester University Hospitals NHS Foundation Trust; and Nowgen, Manchester. Katherine has an interest in the economics of genomic technologies and services and the application to precision medicine. Katherine has an interest in the use of economic evidence to inform decision-making in practice and was a member of a NICE Technology Appraisal Committee between October 2003 and 2012. Katherine has been a member of national funding review panels for projects on the economics of personalised medicine for Canada, UK, The Netherlands, France and Luxembourg. Katherine also has an established interest in communicating the methods and application of economic evaluation to healthcare professionals, including pharmacists, and members of the public.
The overarching goal of JPIAMR research on Surveillance is to standardise, improve and extend surveillance systems on antibiotic use and on AMR in humans, animals, food, and the larger environment. In the network call that opens today, JPIAMR will support leading scientists and experts in the field of AMR surveillance to establish networks to enhance resource alignment and maximise existing and future efforts to combat AMR.
Surveillance networks are essential to monitor the threat of AMR and guide public health policy. In order to understand antibiotic resistance, we must understand whether resistance genes are highly mobile and whether dominant pathogenic clones spread resistance globally. However, countries have different levels and methods of surveillance and many lack national reporting systems leading to major gaps in AMR surveillance and an urgent need to strengthen collaboration on global AMR surveillance.
In partnership with ten member countries; Belgium, France, Germany, Ireland, Italy, Netherlands, Norway, Spain, Sweden, and the United Kingdom, JPIAMR is launching the seventh joint call for transnational networks. The total budget of the call is approximately € 1.1 million.
Applicants are invited to form JPIAMR networks that are expected to provide white papers, prospective views, guidelines and/or best practice/roadmap/systematic reviews and frameworks to identify key questions to be addressed or identify potential solutions to overcome barriers for AMR surveillance and the implementation of surveillance research studies.
In this network call up to 21 networks will be funded with up to € 50 000 each to maximise existing and future efforts to combat AMR by pushing forward new ideas in AMR surveillance. Note that JPIAMR networks calls do not fund research projects.
More information on the 7th call – 2018 Network Call on Surveillance, can be found at the call webpage: utveckling.jpiamr.eu/7thcall/
JPIAMR recognises a need to reinforce alignment of AMR research. To promote this, the JPIAMR will establish a Virtual Research Institute in AMR – a global network connecting research performing organisations, including institutes, centres, and infrastructures.
In partnership with ten member countries; Canada, Egypt, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, and the United Kingdom, JPIAMR is launching the 8th joint call for transnational Networks. The total budget of the call is approximately 1.1 million Euro. This Network Call “Building the Foundation of the JPIAMR Virtual Research Institute” aims to identify research community needs and develop ideas to form the foundation for the JPIAMR-VRI. Networks of motivated groups should develop catalytic ideas and strategic plans to help bring the JPIAMR-VRI to life!
Up to 22 Networks will be funded with up to €50 000 each coordinator to connect experts from research performing organisations and establish expertise clusters in the AMR community. The formation of larger, multi-coordinator Networks is possible according to national rules. This is an ERA-NET JPI-EC-AMR additional activity. Note that JPIAMR Network calls do not fund research projects.
Call procedure
The JPIAMR-VRI Network Call has a one-step procedure. The final funding decision will be announced in October / November 2018.
Deadline
The proposal submission deadline is July 4th, 2018, (17.00 CET).
JPIAMR-VRI Network Call Secretariat and National Points of Contact
The JPIAMR-VRI Network Call Secretariat is hosted by the Italian Ministry of Health, It-MoH.
All questions on the pre-announcement should be sent to: secretariat.jpiamr@vr.se
For more detailed information on the JPIAMR-VRI, please see here.
To download PIAMR-VRI Network Call folder, please click here.
Download the press release in English here: Press Release_JPIAMR-VRI
Download the press release in French here: JPIAMR-IRV_Press Release_FRENCH
More detailed information to be found here: JPIAMR 2018 Network Call: Building the foundation of the JPIAMR-VRI
About
The Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, coordinates national programmes, funding and supports collaborative action for filling knowledge gaps on AMR with a one health approach. Today, 27 nations, from four continents, are members of JPIAMR. More than 300 research groups have received funding from JPIAMR. Since its launch in 2011 JPIAMR has coordinated total budget of 65 million Euros. The JPIAMR Secretariat is hosted by the Swedish Research Council.
The WHO review shows that the current clinical pipeline is still insufficient to mitigate the threat of antimicrobial resistance.
JPIAMR contributes to finding solutions to the challenges presented by WHO. JPIAMR is processing current and future calls that funds research on the very challenges highlighted in the report. Among with several ground breaking activities.
WHO points out:
As of May 2017, a total of 51 antibiotics (including combinations) and 11 biologicals were in the clinical pipeline with 42 new therapeutic entities (33 antibiotics and nine biologicals) that target priority pathogens, seven products for tuberculosis (TB) and nine for C.difficile infections (seven antibiotics and two biologicals) . The qualitative analysis shows a lack of potential treatment options for priority resistant bacteria, especially for multidrug- and extensively drug-resistant Gram-negative pathogens.
The full report is now available, please click here to view it.
To capture research needs more efficiently we urge anyone with interest in the subject to provide input in terms of what knowledge gaps they think should receive priority. Please provide here your input before September 17th.
Now twenty transnational research projects are invited to submit full applications within the JPIAMRs fifth Joint Call on Prevention and Intervention Strategies to control AMR infections.
Earlier this year the JPIAMR announced its fifth joint call on “Prevention and Intervention Strategies to control AMR infections”. As the deadline for submitting a pre-proposal passed on March 21st, 53 transnational consortia had submitted applications. After evaluation by a panel of international reviewers, twenty of the projects have been invited to submit a full application. The deadline for the full application is on July 4th. For more information, please visit the call page.
Facts about the fifth joint call:
The JPIAMR, in partnership with fifteen countries: Belgium, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Latvia, Netherlands, Norway, Poland, Romania, Spain, Sweden and Switzerland, launched a fifth joint call for transnational research Projects.
The call targets research in the following topic:
Comparison of prevention, control and intervention strategies for AMR infections through multidisciplinary studies, including One Health approaches.
When the G20 Health Ministers recently met in Germany, AMR was at the very top of their agenda. Germany who holds the G20 presidency described it as an” important breakthrough”, that all nations agreed to address the growing antibiotic resistance in the world.
In the declaration from the meeting, the G20 Health Ministers pointed out JPIAMR as one of the key initiatives to support, by concluding “we commit to broaden the voluntary financial support for these initiatives. We call on other countries, philanthropic organizations, academia and the private sector to support these initiatives”.
JPIAMR support new evidence and innovations that reduce the burden of antimicrobial resistance through coordinated global collaborative research in Europe and around the world. Also aiming to undertake further research to better understand how resistance develops and spreads in the environment. And to develop diagnostic tools and better surveillance methods as well as validating smarter strategies for using antibiotics in healthcare and agriculture. Today 24 countries have joined JPIAMR as members. The collaborative platform is now internationally recognized.
Please follow this link to read the whole statement from the G20 Health Minister meeting in Germany on May 19, 2017. https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/G/G20-Gesundheitsministertreffen/G20_Health_Ministers_Declaration_engl.pdf
AMR Call from Southeast Asia – Europe Joint Funding Scheme for Research and Innovation (SEA-EU-NET)
The JPIAMR members Belgium, France, Germany, Poland, Spain, Sweden, Switzerland, and Turkey participate in a joint call with the South-East Asian countries Cambodia, Lao PDR, The Phillipines, Thailand, and Vietnam within the framework of the EU-funded project SEA-EU-NET.
The call cover over the thematic areas of Health (Anti-microbial drug resistance, Emerging infectious diseases), Environment/ Climate Change (Adaptation/Resilience of food production systems, Impacts of Climate Change on Ecosystems/Biodiversity) with aim to enhance bi-regional co-operation and develop new partnerships as well as strengthen existing ones.
Deadline for submission: 30 June 2017, 18.00 CET
For more information on the call and application, please see:
Southeast Asia – Europe Joint Funding Scheme for Research and Innovation
